Short Takes

President Trump has announced his intention to nominate cancer specialist Dr. Stephen Hahn to be the next Commissioner of the Food and Drug Administration (FDA). Dr. Hahn currently serves as the Chief Medical Officer at MD Anderson Cancer Center in Texas, where he oversees clinical care. He previously worked at the National Cancer Institute and the University of Pennsylvania medical school, where he chaired the radiation oncology department for nine years. Until Dr. Hahn is confirmed by the Senate, Brett Giroir, Assistant Secretary for Health at the Department of Health and Human Services, will oversee the FDA. The Biological Sciences Directorate (BIO) at the National Science Foundation (NSF) has announced a new funding opportunity for the Biology Integration Institutes (BII) program, which promotes teams of researchers to investigate questions that incorporates many disciplines and can exceed biology. BIO is prioritizing support for fundamental biological research that takes an integrative approach to understanding life's key innovations and aims to strengthen the connections between biological subdisciplines and encourage a reintegration of biology through this new funding opportunity. Letters of Intent are due on December 20, 2019 and full proposals are due on February 6, 2020. More information at https://www.nsf.gov/pubs/2020/nsf20508/nsf20508.htm The National Academies of Sciences, Engineering, and Medicine's (NASEM) Committee on Assistance to the U.S. Fish & Wildli...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news